Published • loading... • Updated
Araceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery
The platform generates rapid kinetic imaging across entire 1536-well plates to support Lab-in-the-Loop workflows for AI-driven drug discovery.
- On Wednesday, Araceli Biosciences launched Endeavor Live Cell, extending its ultra-high-throughput imaging platform into dynamic biology at screening scale.
- As AI-driven drug discovery evolves toward Lab-in-the-Loop workflows, researchers need high-quality cellular data generated quickly and consistently, not just end-point measurements.
- Developed in partnership with Okolab, the system leverages environmental control expertise to enable approximately four-minute imaging timepoints across entire 1536-well plates.
- Matt Beaudet, President and CEO of Araceli Biosciences, said, "This launch is an important extension of the Araceli platform," emphasizing high-quality biological data generation.
- Lara Petrak, Director of Sales for Okolab USA, noted the partnership gives scientists "a powerful new way to study dynamic biology" for AI-enabled drug discovery.
Insights by Ground AI
11 Articles
11 Articles
Montana Standard+10 Reposted by 10 other sources
Araceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery
Endeavor® Live Cell enables rapid kinetic imaging across large scale screening campaigns, generating the cellular data needed to support Lab-in-the-Loop drug discovery workflows.
Coverage Details
Total News Sources11
Leaning Left0Leaning Right0Center9Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
